(4S,5R)-3-[[5-[5-(4-acetyl-2,6-dimethylphenyl)-2-methoxy-3-pyridinyl]-2-(3,3-difluoroazetidin-1-yl)-4-pyridinyl]methyl]-4-methyl-5-[3-methyl-5-(trifluoromethyl)phenyl]-1,3-oxazolidin-2-one;(4S,5R)-3-[[3-[5-(4-acetyl-2-methylphenyl)-2-methoxy-3-pyridinyl]-6-(3-fluoroazetidin-1-yl)-2-pyridinyl]methyl]-4-methyl-5-[3-methyl-5-(trifluoromethyl)phenyl]-1,3-oxazolidin-2-one;tert-butyl 4-[5-[6-(3-fluoroazetidin-1-yl)-2-[[(4S,5R)-4-methyl-5-[3-methyl-5-(trifluoromethyl)phenyl]-2-oxo-1,3-oxazolidin-3-yl]methyl]-3-pyridinyl]-6-methoxy-3-pyridinyl]-3-methylbenzoate
C112H109F13N12O13 — CID 158836371
Data last refreshed: (MolForge compound catalog, from PubChem)
About (4S,5R)-3-[[5-[5-(4-acetyl-2,6-dimethylphenyl)-2-methoxy-3-pyridinyl]-2-(3,3-difluoroazetidin-1-yl)-4-pyridinyl]methyl]-4-methyl-5-[3-methyl-5-(trifluoromethyl)phenyl]-1,3-oxazolidin-2-one;(4S,5R)-3-[[3-[5-(4-acetyl-2-methylphenyl)-2-methoxy-3-pyridinyl]-6-(3-fluoroazetidin-1-yl)-2-pyridinyl]methyl]-4-methyl-5-[3-methyl-5-(trifluoromethyl)phenyl]-1,3-oxazolidin-2-one;tert-butyl 4-[5-[6-(3-fluoroazetidin-1-yl)-2-[[(4S,5R)-4-methyl-5-[3-methyl-5-(trifluoromethyl)phenyl]-2-oxo-1,3-oxazolidin-3-yl]methyl]-3-pyridinyl]-6-methoxy-3-pyridinyl]-3-methylbenzoate
(4S,5R)-3-[[5-[5-(4-acetyl-2,6-dimethylphenyl)-2-methoxy-3-pyridinyl]-2-(3,3-difluoroazetidin-1-yl)-4-pyridinyl]methyl]-4-methyl-5-[3-methyl-5-(trifluoromethyl)phenyl]-1,3-oxazolidin-2-one;(4S,5R)-3-[[3-[5-(4-acetyl-2-methylphenyl)-2-methoxy-3-pyridinyl]-6-(3-fluoroazetidin-1-yl)-2-pyridinyl]methyl]-4-methyl-5-[3-methyl-5-(trifluoromethyl)phenyl]-1,3-oxazolidin-2-one;tert-butyl 4-[5-[6-(3-fluoroazetidin-1-yl)-2-[[(4S,5R)-4-methyl-5-[3-methyl-5-(trifluoromethyl)phenyl]-2-oxo-1,3-oxazolidin-3-yl]methyl]-3-pyridinyl]-6-methoxy-3-pyridinyl]-3-methylbenzoate (PubChem CID 158836371) has the molecular formula C112H109F13N12O13 and a molecular weight of 2078.15 g/mol. Its IUPAC name is (4S,5R)-3-[[5-[5-(4-acetyl-2,6-dimethylphenyl)-2-methoxy-3-pyridinyl]-2-(3,3-difluoroazetidin-1-yl)-4-pyridinyl]methyl]-4-methyl-5-[3-methyl-5-(trifluoromethyl)phenyl]-1,3-oxazolidin-2-one;(4S,5R)-3-[[3-[5-(4-acetyl-2-methylphenyl)-2-methoxy-3-pyridinyl]-6-(3-fluoroazetidin-1-yl)-2-pyridinyl]methyl]-4-methyl-5-[3-methyl-5-(trifluoromethyl)phenyl]-1,3-oxazolidin-2-one;tert-butyl 4-[5-[6-(3-fluoroazetidin-1-yl)-2-[[(4S,5R)-4-methyl-5-[3-methyl-5-(trifluoromethyl)phenyl]-2-oxo-1,3-oxazolidin-3-yl]methyl]-3-pyridinyl]-6-methoxy-3-pyridinyl]-3-methylbenzoate.
Molecular Properties
| Compound Name | (4S,5R)-3-[[5-[5-(4-acetyl-2,6-dimethylphenyl)-2-methoxy-3-pyridinyl]-2-(3,3-difluoroazetidin-1-yl)-4-pyridinyl]methyl]-4-methyl-5-[3-methyl-5-(trifluoromethyl)phenyl]-1,3-oxazolidin-2-one;(4S,5R)-3-[[3-[5-(4-acetyl-2-methylphenyl)-2-methoxy-3-pyridinyl]-6-(3-fluoroazetidin-1-yl)-2-pyridinyl]methyl]-4-methyl-5-[3-methyl-5-(trifluoromethyl)phenyl]-1,3-oxazolidin-2-one;tert-butyl 4-[5-[6-(3-fluoroazetidin-1-yl)-2-[[(4S,5R)-4-methyl-5-[3-methyl-5-(trifluoromethyl)phenyl]-2-oxo-1,3-oxazolidin-3-yl]methyl]-3-pyridinyl]-6-methoxy-3-pyridinyl]-3-methylbenzoate |
|---|---|
| PubChem CID | 158836371 |
| Molecular Formula | C112H109F13N12O13 |
| Molecular Weight | 2078.15 g/mol |
| Exact Mass | 2076.80 |
| IUPAC Name | (4S,5R)-3-[[5-[5-(4-acetyl-2,6-dimethylphenyl)-2-methoxy-3-pyridinyl]-2-(3,3-difluoroazetidin-1-yl)-4-pyridinyl]methyl]-4-methyl-5-[3-methyl-5-(trifluoromethyl)phenyl]-1,3-oxazolidin-2-one;(4S,5R)-3-[[3-[5-(4-acetyl-2-methylphenyl)-2-methoxy-3-pyridinyl]-6-(3-fluoroazetidin-1-yl)-2-pyridinyl]methyl]-4-methyl-5-[3-methyl-5-(trifluoromethyl)phenyl]-1,3-oxazolidin-2-one;tert-butyl 4-[5-[6-(3-fluoroazetidin-1-yl)-2-[[(4S,5R)-4-methyl-5-[3-methyl-5-(trifluoromethyl)phenyl]-2-oxo-1,3-oxazolidin-3-yl]methyl]-3-pyridinyl]-6-methoxy-3-pyridinyl]-3-methylbenzoate |
| SMILES | COc1ncc(-c2c(C)cc(C(C)=O)cc2C)cc1-c1cnc(N2CC(F)(F)C2)cc1CN1C(=O)O[C@H](c2cc(C)cc(C(F)(F)F)c2)[C@@H]1C.COc1ncc(-c2ccc(C(=O)OC(C)(C)C)cc2C)cc1-c1ccc(N2CC(F)C2)nc1CN1C(=O)O[C@H](c2cc(C)cc(C(F)(F)F)c2)[C@@H]1C.COc1ncc(-c2ccc(C(C)=O)cc2C)cc1-c1ccc(N2CC(F)C2)nc1CN1C(=O)O[C@H](c2cc(C)cc(C(F)(F)F)c2)[C@@H]1C |
| InChI | InChI=1S/C39H40F4N4O5.C37H35F5N4O4.C36H34F4N4O4/c1-21-12-25(15-27(13-21)39(41,42)43)34-23(3)47(37(49)51-34)20-32-30(10-11-33(45-32)46-18-28(40)19-46)31-16-26(17-44-35(31)50-7)29-9-8-24(14-22(29)2)36(48)52-38(4,5)6;1-19-7-25(11-28(8-19)37(40,41)42)33-22(4)46(35(48)50-33)16-27-13-31(45-17-36(38,39)18-45)43-15-30(27)29-12-26(14-44-34(29)49-6)32-20(2)9-24(23(5)47)10-21(32)3;1-19-10-24(13-26(11-19)36(38,39)40)33-21(3)44(35(46)48-33)18-31-29(8-9-32(42-31)43-16-27(37)17-43)30-14-25(15-41-34(30)47-5)28-7-6-23(22(4)45)12-20(28)2/h8-17,23,28,34H,18-20H2,1-7H3;7-15,22,33H,16-18H2,1-6H3;6-15,21,27,33H,16-18H2,1-5H3/t23-,34-;22-,33-;21-,33-/m000/s1 |
| InChIKey | IXROJQIUUIDJRO-GTAFVWNOSA-N |
| XLogP | 25.05 |
| TPSA | 263.81 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 22 |
| Rotatable Bonds | 24 |
| Heavy Atoms | 150 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2078.15 |
| LogP ≤ 5 | 25.05 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 22 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158836371 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.